November 17-20, 2019
Meet with our Business Development and Toxicology leadership at the 40th Annual Meeting of the American College of Toxicology.
Learn about our capabilities in immuno-oncology and gene therapy toxicology to effectively move new therapeutics towards the clinic. Our infectious disease group provides a long history of immunoassay, immunoprofiling, microbiology, and virology experience to precisely monitor the immune response elicited from emerging therapeutic approaches.
Request a meeting with our attending staff:
William Johnson, PhD, DABT, Toxicology Division Manager
Todd Bucciarelli, MBA, Director of Business Development